The Vice President for Research Office has collected a list of extramural funding opportunities as part of our on-going commitment to support equitable, diverse, and inclusive research on our campus and in our broader communities. All available opportunities are also published on this site, and will be updated bi-monthly. Please check each sponsor’s solicitation for the most up-to-date information for each program, as the sponsor may have changed details of the opportunity since it was posted here.
If you are considering applying for a DEI-related funding opportunity and would like grant development support, please contact Mercedes Ward, Grant Development Specialist for Equity, Diversity, and Inclusion.
NATIONAL INSTITUTES OF HEALTH (NIH)
NIH Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
Amount: $500,000 direct costs per year
Deadline: November 8, 2023
The purpose of this initiative is to support investigator-initiated research in genomics and health equity, with the ultimate goal of developing approaches, generating and disseminating data, and implementing metrics or interventions that will advance the equitable use of genomics to improve health in U.S. populations. Awardees will conduct innovative and generalizable research in genomics and health equity spanning across genomic research areas and will incorporate a plan for enhancing diverse perspectives. Applications supporting New or Early Stage Investigators from diverse backgrounds, including those from groups traditionally underrepresented in the biomedical, behavioral, and clinical research workforce, as described in the NIH Notice of Interest in Diversity (NOT-OD-20-031), are encouraged. See also RFA-HG-23-018.
NIH Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)
Amount: $200,000 direct costs per year
Deadline: November 8, 2023
The purpose of this initiative is to support investigator-initiated research in genomics and health equity, with the ultimate goal of developing approaches, generating and disseminating data, and implementing metrics or interventions that will advance the equitable use of genomics to improve health in U.S. populations. Awardees will conduct innovative and generalizable research in genomics and health equity spanning across genomic research areas and will incorporate a plan for enhancing diverse perspectives. This R21 Notice of Funding Opportunity (NOFO) will support small research projects that can be carried out in a short period of time with limited resources. The R21 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. Applications supporting New or Early Stage Investigators from diverse backgrounds, including those from groups traditionally underrepresented in the biomedical, behavioral, and clinical research workforce, as described in the NIH Notice of Interest in Diversity (NOT-OD-20-031), are encouraged. See also RFA-HG-23-017.